LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Search

Lyell Immunopharma Inc

Fechado

12.87 0.78

Visão Geral

Variação de preço das ações

24h

Atual

Mín

11.94

Máximo

13.24

Indicadores-chave

By Trading Economics

Rendimento

9.5M

-43M

Vendas

1K

8K

EPS

-2.89

Margem de lucro

-533,550

Funcionários

300

EBITDA

11M

-43M

Recomendações

By TipRanks

Recomendações

Vender

Previsão para 12 meses

-15.58% downside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

47M

250M

Abertura anterior

12.09

Fecho anterior

12.87

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Lyell Immunopharma Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de set. de 2025, 23:37 UTC

Ações em Alta

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 de set. de 2025, 20:41 UTC

Ganhos

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 de set. de 2025, 20:30 UTC

Ganhos

GameStop 2Q Sales, Profit Rise

9 de set. de 2025, 23:19 UTC

Conversa de Mercado

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 de set. de 2025, 21:35 UTC

Ganhos

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 21:32 UTC

Ganhos

Oracle's Backlog Swells With Big Customer Deals -- Update

9 de set. de 2025, 21:02 UTC

Aquisições, Fusões, Aquisições de Empresas

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de set. de 2025, 20:33 UTC

Ganhos

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 de set. de 2025, 20:26 UTC

Ganhos

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 20:23 UTC

Ganhos

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 de set. de 2025, 20:12 UTC

Ganhos

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 de set. de 2025, 20:10 UTC

Ganhos

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 de set. de 2025, 20:10 UTC

Ganhos

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 de set. de 2025, 20:09 UTC

Ganhos

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 de set. de 2025, 20:09 UTC

Ganhos

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 de set. de 2025, 20:08 UTC

Ganhos

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 de set. de 2025, 20:07 UTC

Ganhos

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 de set. de 2025, 20:06 UTC

Ganhos

Oracle 1Q Software Revenue $5.72B >ORCL

9 de set. de 2025, 20:06 UTC

Ganhos

Synopsys 3Q Adj EPS $3.39 >SNPS

9 de set. de 2025, 20:06 UTC

Ganhos

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Rev $14.93B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q EPS $1.01 >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Synopsys 3Q EPS $1.50 >SNPS

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Services Revenue $1.35B >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Adj EPS $1.47 >ORCL

9 de set. de 2025, 20:05 UTC

Ganhos

Oracle 1Q Hardware Revenue $670M >ORCL

Comparação entre Pares

Variação de preço

Lyell Immunopharma Inc Previsão

Preço-alvo

By TipRanks

-15.58% parte inferior

Previsão para 12 meses

Média 11 USD  -15.58%

Máximo 12 USD

Mínimo 10 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Lyell Immunopharma Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Vender

3 ratings

0

Comprar

2

Manter

1

Vender

Pontuação Técnica

By Trading Central

0.4217 / 0.4691Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

help-icon Live chat